Abstract

PURPOSE: Adverse drug reactions to anti-tuberculosis therapy remain clinically challenging. Tolerability to these agents is lower in HIV patients. These reactions are less well studied in multiethnic Asian populations. We looked at the prevalence and profile of major adverse drug reactions between HIV and non-HIV patients on anti-TB treatment in such a population.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call